0000025743-23-000001.txt : 20230711 0000025743-23-000001.hdr.sgml : 20230711 20230710174947 ACCESSION NUMBER: 0000025743-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230711 DATE AS OF CHANGE: 20230710 EFFECTIVENESS DATE: 20230711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TherapeuticsMD, Inc. CENTRAL INDEX KEY: 0000025743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870233535 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-486406 FILM NUMBER: 231080732 BUSINESS ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 561-961-1900 MAIL ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: AMHN, Inc. DATE OF NAME CHANGE: 20090930 FORMER COMPANY: FORMER CONFORMED NAME: CROFF ENTERPRISES INC DATE OF NAME CHANGE: 19970915 FORMER COMPANY: FORMER CONFORMED NAME: CROFF OIL CO DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0708 D LIVE 0000025743 TherapeuticsMD, Inc. 951 YAMATO ROAD, SUITE 220 BOCA RATON FL FLORIDA 33431 561-961-1900 NEVADA AMHN, Inc. CROFF ENTERPRISES INC CROFF OIL CO Corporation true Michael C. Donegan 951 Yamato Road Suite 220 Boca Raton FL FLORIDA 33431 Executive Officer Tommy G. Thompson 951 Yamato Road Suite 220 Boca Raton FL FLORIDA 33431 Director Gail Naughton 951 Yamato Road Suite 220 Boca Raton FL FLORIDA 33431 Director Cooper C. Collins 951 Yamato Road Suite 220 Boca Raton FL FLORIDA 33431 Director Marlan Walker 951 Yamato Road Suite 220 Boca Raton FL FLORIDA 33431 Executive Officer Justin Roberts 951 Yamato Road Suite 220 Boca Raton FL FLORIDA 33431 Director Pharmaceuticals Decline to Disclose 06b false 2023-06-29 false true false 0 5000000 1149998 3850002 Pursuant to a Subscription Agreement with Rubric Capital Management LP, the Company may sell, at the Company's election, up to an aggregate of 5,000,000 shares of the Company's common stock, at an aggregate purchase price of up to $5,000,000. false 2 0 0 0 false TherapeuticsMD, Inc. /s/ Marlan Walker Marlan Walker Chief Executive Officer 2023-07-10